<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32142934</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1220</ISSN><JournalIssue CitedMedium="Internet"><Volume>200</Volume><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of steroid biochemistry and molecular biology</Title><ISOAbbreviation>J Steroid Biochem Mol Biol</ISOAbbreviation></Journal><ArticleTitle>The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>105650</StartPage><MedlinePgn>105650</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsbmb.2020.105650</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0960-0760(20)30018-2</ELocationID><Abstract><AbstractText>Extra-renal expression of Cytochrome P450 Family 27 Subfamily B Member 1 (CYP27B1) has been well recognized and reflects the importance of intracrine/paracrine vitamin D signaling in different tissues under physiological and pathological conditions. In a prior RNA sequencing project, we identified CYP27B1 mRNA as upregulated in muscle samples from patients with amyotrophic lateral sclerosis (ALS) compared to normal controls. Our aims here were: (1) to validate this finding in a larger sample set including disease controls, (2) to determine which cell type is expressing CYP27B1 protein in muscle tissue, (3) to correlate CYP27B1 mRNA expression with disease progression in the SOD1<sup>G93A</sup> ALS mouse and in ALS patients. We assessed CYP27B1 expression by qPCR, western blot, and immunohistochemistry in a repository of muscle samples from ALS, disease controls (myopathy and non-ALS neuropathic disease), normal subjects, and muscle samples from the SOD1<sup>G93A</sup> mouse. Eight ALS patients were studied prospectively over 6-12 months with serial muscle biopsies. We found that CYP27B1 mRNA and protein levels were significantly increased in ALS versus normal and myopathy muscle samples. Neuropathy samples had increased CYP27B1 mRNA and protein expression but at a lower level than the ALS group. Immunohistochemistry showed that CYP27B1 localized to myofibers, especially those with features of denervation. In the SOD1<sup>G93A</sup> mouse, CYP27B1 mRNA and protein were detected in skeletal muscle in early pre-symptomatic stages and increased through end-stage. In the human study, increases in CYP27B1 mRNA in muscle biopsies correlated with disease progression rates over the same time period. In summary, we show for the first time that CYP27B1 mRNA and protein expression are elevated in muscle fibers in denervating disease, especially ALS, where mRNA levels can potentially serve as a surrogate marker for tracking disease progression. Its upregulation may reflect a local perturbation of vitamin D signaling, and further characterization of this pathway may provide insight into underlying molecular processes linked to muscle denervation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA; Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazamel</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ikjae</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamman</LastName><ForeName>Marcas</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA; Department of Cell, Developmental, and Integrative Biology, and Medicine, University of Alabama, Birmingham, AL 35294, USA; Department of Medicine, University of Alabama, Birmingham, AL 35294, USA; Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental, and Integrative Biology, and Medicine, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Thaddaeus</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Peter H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama, Birmingham, AL 35294, USA; Department of Cell, Developmental, and Integrative Biology, and Medicine, University of Alabama, Birmingham, AL 35294, USA; Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA. Electronic address: phking@uabmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX001148</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004419</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092651</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS111275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Steroid Biochem Mol Biol</MedlineTA><NlmUniqueID>9015483</NlmUniqueID><ISSNLinking>0960-0760</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.15.18</RegistryNumber><NameOfSubstance UI="D015090">25-Hydroxyvitamin D3 1-alpha-Hydroxylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.15.18</RegistryNumber><NameOfSubstance UI="C000600378">CYP27B1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015090" MajorTopicYN="N">25-Hydroxyvitamin D3 1-alpha-Hydroxylase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">CYP27B1</Keyword><Keyword MajorTopicYN="N">Disease progression</Keyword><Keyword MajorTopicYN="N">Muscle biopsy</Keyword><Keyword MajorTopicYN="N">Muscle denervation</Keyword><Keyword MajorTopicYN="N">SOD1(G93A) mouse</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32142934</ArticleId><ArticleId IdType="mid">NIHMS1581605</ArticleId><ArticleId IdType="pmc">PMC7274892</ArticleId><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105650</ArticleId><ArticleId IdType="pii">S0960-0760(20)30018-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bikle DD, Patzek S, Wang Y, Physiologic and pathophysiologic roles of extra renal CYP27B1: Case report and review, Bone reports, 8 (2018) 255&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6021194</ArticleId><ArticleId IdType="pubmed">29963603</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams JS, Rafison B, Witzel S, Reyes RE, Shieh A, Chun R, Zavala K, Hewison M, Liu PT, Regulation of the extrarenal CYP27B1-hydroxylase, J Steroid Biochem Mol Biol, 144 (2014) 22&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077994</ArticleId><ArticleId IdType="pubmed">24388948</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones G, Prosser DE, Kaufmann M, The Activating Enzymes of Vitamin D Metabolism (25- and 1&#x3b1;-Hydroxylases), in: Feldman D (Ed.) Vitamin D (4th Ed), Academic Press; 2018, pp. 57&#x2013;79.</Citation></Reference><Reference><Citation>Hardiman O, van den Berg LH, Kiernan MC, Clinical diagnosis and management of amyotrophic lateral sclerosis, Nat Rev Neurol, 7 (2011) 639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Cui X, Kim S, Wians R, Sorge R, Oh SJ, Kwan T, AlSharabati M, Lu L, Claussen G, Anderson T, Yu S, Morgan D, Kazamel M, King PH, Smads as muscle biomarkers in amyotrophic lateral sclerosis, Ann Clin Transl Neurol, 1 (2014) 778&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4241805</ArticleId><ArticleId IdType="pubmed">25493269</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S, King A, Cleveland M, Pradat P-F, Corse A, Rothstein JD, Leigh PN, Abila B, Bates S, Wurthner J, Meininger V, Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study, Acta Neuropathol Com, 2 (2014) 165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297389</ArticleId><ArticleId IdType="pubmed">25510661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD, Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man, Experimental Neurology, 185 (2004) 232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J, ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease, Front. Neurosci., 8 (2014) 252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, Biological markers in amyotrophic lateral sclerosis: help or hindrance?, J Neurol 246 (1999) III13&#x2013;III15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10631655</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Boylan K, Jeromin A, Rutkove SB, Berry J, Atassi N, Bruijn L, ALS biomarkers for therapy development: State of the field and future directions, Muscle Nerve, 53 (2016) 169&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718795</ArticleId><ArticleId IdType="pubmed">26574709</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, a. et, Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation, Science, 264 (1994) 1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, Byers N, Toman I, Alexander GM, Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS, J. Neurol. Sci, 236 (2005) 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World D Federation of Neurology Research Group on Motor Neuron, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph. Lateral Scler., 1 (2000) 293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans WJ, Phinney SD, Young VR, Suction applied to a muscle biopsy maximizes sample size, Med Sci Sports Exerc, 14 (1982) 101&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">7070249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickel CS, Cross JM, Bamman MM, Exercise dosing to retain resistance training adaptations in young and older adults, Med Sci Sports Exerc, 43 (2011) 1177&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pubmed">21131862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazamel M, Cutter G, Claussen G, Alsharabati M, Oh SJ, Lu L, King PH, Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population, Amyotroph Lateral Scler Frontotemporal Degener, 14 (2013) 334&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3732496</ArticleId><ArticleId IdType="pubmed">23458155</ArticleId></ArticleIdList></Reference><Reference><Citation>Brozyna AA, Jozwicki W, Jochymski C, Slominski AT, Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas, Oncol. Rep, 33 (2015) 599&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306272</ArticleId><ArticleId IdType="pubmed">25501638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Ren S, Nguyen L, Adams JS, Hewison M, Splice Variants of the CYP27B1 Gene and the Regulation of 1,25-Dihydroxyvitamin D3 Production, Endocrinology, 148 (2007) 3410&#x2013;3418.</Citation><ArticleIdList><ArticleId IdType="pubmed">17395703</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Kim S, Cui X, Zheng L, Oh SJ, Anderson T, AlSharabati M, Kazamel M, Volpicelli-Daley L, Bamman MM, Yu S, King PH, Transforming Growth Factor Beta (TGF-beta) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression, PLoS One, 10 (2015) e0138425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574401</ArticleId><ArticleId IdType="pubmed">26375954</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomeni R, Fava M, Amyotrophic lateral sclerosis disease progression model, Amyotroph Lateral Scler Frontotemporal Degener, 15 (2014) 119&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">24070404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, Shinoda K, Sugino M, Hanafusa T, Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS, Neurology, 66 (2006) 265&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Ruggieri M, Cortese R, D&#x2019;Errico E, Capozzo R, Leo A, Mastrapasqua M, Zoccolella S, Leante R, Livrea P, Logroscino G, Simone IL, Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression, Eur J Neurol, 19 (2012) 1561&#x2013;1567.</Citation><ArticleIdList><ArticleId IdType="pubmed">22680408</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikuea R, Zhang X, Park-Sarge OK, Esser KA, VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation, Am. J. Physiol. Cell Physiol, 303 (2012) C396&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422988</ArticleId><ArticleId IdType="pubmed">22648952</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer MB, Pike JW, Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of CYP27B1 and Cyp24a1 expression, J Steroid Biochem Mol Biol, 196 (2020) 105500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954286</ArticleId><ArticleId IdType="pubmed">31629064</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer MB, Benkusky NA, Kaufmann M, Lee SM, Onal M, Jones G, Pike JW, A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene CYP27B1 essential for vitamin D3 activation, Journal of Biological Chemistry, 292 (2017) 17541&#x2013;17558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655528</ArticleId><ArticleId IdType="pubmed">28808057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Liu X, Wang H, Li Y, Lan N, Yuan X, Wu M, Liu Z, Li G, Allergen specific immunotherapy enhanced defense against bacteria via TGF-beta1-induced CYP27B1 in asthma, Oncotarget, 8 (2017) 68681&#x2013;68695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5620288</ArticleId><ArticleId IdType="pubmed">28978148</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zugel U, Bikle DD, Modlin RL, Gallo RL, Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism, J Clin Invest, 117 (2007) 803&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1784003</ArticleId><ArticleId IdType="pubmed">17290304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki Y, Ojima K, Uezumi A, Masuda S, Yoshimura K, Takeda S.i, Participation of bone marrow-derived cells in fibrotic changes in denervated skeletal muscle, Am J Pathol, 166 (2005) 1721&#x2013;1732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1602421</ArticleId><ArticleId IdType="pubmed">15920157</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, Kovacs M, Moura IC, Beckman JS, Hermine O, Barbeito L, Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS, JCI Insight, 3 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai K, Tsai M, Saito H, Galli SJ, Mast cells as sources of cytokines, chemokines, and growth factors, Immunological reviews, 282 (2018) 121&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5813811</ArticleId><ArticleId IdType="pubmed">29431212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecchio C, Micheletti A, Cassatella MA, Neutrophil-derived cytokines: facts beyond expression, Front. Immunol, 5 (2014) 508&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4204637</ArticleId><ArticleId IdType="pubmed">25374568</ArticleId></ArticleIdList></Reference><Reference><Citation>Pojednic RM, Ceglia L, The emerging biomolecular role of vitamin D in skeletal muscle, Exerc Sport Sci Rev, 42 (2014) 76&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369924</ArticleId><ArticleId IdType="pubmed">24508736</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifondorwa DJ, Thompson TD, Wiley J, Culver AE, Shetler PK, Rocha GV, Ma YL, Krishnan V, Bryant HU, Vitamin D and/or calcium deficient diets may differentially affect muscle fiber neuromuscular junction innervation, Muscle Nerve, 54 (2016) 1120&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">27074419</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceglia L, Harris SS, Vitamin D and its role in skeletal muscle, Calcif Tissue Int, 92 (2013) 151&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">22968766</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvagno F, Pescarmona G, Spotlight on vitamin D receptor, lipid metabolism and mitochondria: Some preliminary emerging issues, Molecular and Cellular Endocrinology, 450 (2017) 24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">28414049</ArticleId></ArticleIdList></Reference><Reference><Citation>Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE, The Roles of Vitamin D in Skeletal Muscle: Form, Function, and Metabolism, Endocr. Rev, 34 (2013) 33&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">23169676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E, Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis, Acta neuropathologica, 133 (2017) 863&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Turner MR, Wuu J, Defining pre-symptomatic amyotrophic lateral sclerosis, Amyotroph Lateral Scler Frontotemporal Degener, (2019) 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613999</ArticleId><ArticleId IdType="pubmed">30892087</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Cui X, Crossman DK, Hao J, Kazamel M, Kwon Y, King PH, Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis, Neurobiol Dis, 114 (2018) 85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891369</ArticleId><ArticleId IdType="pubmed">29486297</ArticleId></ArticleIdList></Reference><Reference><Citation>Rempel BP, Price EW, Phenix CP, Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT, Molecular Imaging, 16 (2017) 1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5613853</ArticleId><ArticleId IdType="pubmed">28927325</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu W, Tremblier B, Plassot C, Alphandery S, Salsac C, Pageot N, Juntas-Morales R, Scamps F, Daures JP, Raoul C, Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis, Neurobiol Aging, 35 (2014) 1198&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pubmed">24378089</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Macklin EA, Karam C, Yu H, Gonterman F, Fetterman KA, Cudkowicz M, Berry J, Wills AM, Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis, Muscle Nerve, 56 (2017) 726&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">28044349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Park J-S, Oh K-W, Oh S.-i, Park H-M, Kim SH, Vitamin D levels are not predictors of survival in a clinic population of patients with ALS, J. Neurol. Sci, 367 (2016) 83&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27423568</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Madji Hounoum B, Dufour-Rainfray D, Patin F, Maillot F, Beltran S, Gordon PH, Andres CR, Corcia P, Vitamin D is Not a Protective Factor in ALS, CNS Neurosci Ther, 21 (2015) 651&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495158</ArticleId><ArticleId IdType="pubmed">26096806</ArticleId></ArticleIdList></Reference><Reference><Citation>Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, Frasca V, Inghilleri M, Vitamin D in amyotrophic lateral sclerosis, Functional neurology, 32 (2017) 35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505528</ArticleId><ArticleId IdType="pubmed">28380322</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirks-Naylor AJ, Lennon-Edwards S, The effects of vitamin D on skeletal muscle function and cellular signaling, J Steroid Biochem Mol Biol, 125 (2011) 159&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">21397021</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltin B, Gollnick PD, Skeletal Muscle Adaptability: Significance for Metabolism and Performance, Comprehensive Physiology, John Wiley &amp; Sons, Inc; 2010.</Citation></Reference><Reference><Citation>Gollnick PD, Sj&#xf6;din B, Karlsson J, Jansson E, Saltin B, Human soleus muscle: A comparison of fiber composition and enzyme activities with other leg muscles, Pfl&#xfc;gers Archiv, 348 (1974) 247&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">4275915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>